PNPLA3 and metabolic dysfunction-associated steatohepatitis: On the one hand, genetic factors such as polymorphisms in patatin-like phospholipase domain–containing 3 (PNPLA3) and transmembrane 6 superfamily, member 2 (TM6SF2) promote the development of NASH.